HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,570,355 | +158.6% | 3,310,180 | 0.0% | 0.00% | – |
| Q4 2022 | $994,047 | -40.5% | 3,310,180 | +0.1% | 0.00% | – |
| Q3 2022 | $1,672,000 | -11.7% | 3,308,523 | 0.0% | 0.00% | – |
| Q2 2022 | $1,894,000 | -55.6% | 3,308,523 | 0.0% | 0.00% | – |
| Q1 2022 | $4,268,000 | +12.6% | 3,308,523 | -0.5% | 0.00% | – |
| Q4 2021 | $3,792,000 | -25.6% | 3,326,017 | -0.1% | 0.00% | – |
| Q3 2021 | $5,096,000 | -22.7% | 3,330,741 | 0.0% | 0.00% | – |
| Q2 2021 | $6,595,000 | +7.6% | 3,330,741 | -0.0% | 0.00% | – |
| Q1 2021 | $6,129,000 | +61.9% | 3,331,196 | +92.7% | 0.00% | – |
| Q4 2020 | $3,786,000 | – | 1,728,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 51,989 | $79,543,000 | 0.24% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 133,500 | $204,000 | 0.10% |
| Ikarian Capital, LLC | 553,273 | $847,000 | 0.06% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $23,000 | 0.01% |
| Prospera Financial Services Inc | 30,300 | $46,000 | 0.00% |
| Fort Point Capital Partners LLC | 10,000 | $15,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $85,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 6,501 | $10,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,800 | $76,000 | 0.00% |